openPR Logo
Press release

Live Attenuated Vaccines Market Size, Share, Volume and Forecast Report 2023-2030

10-31-2023 10:45 AM CET | Health & Medicine

Press release from: DataM Intelligence 4Market Research

DataM Intelligence 4 Market Research

DataM Intelligence 4 Market Research

The Live Attenuated Vaccines Market is expected to grow at a high CAGR during the forecast period 2023-2030. North America region has the highest market share in the Live Attenuated Vaccines Market, and it is further continuing its dominance during the forecast period.

Browse Full Report at: https://www.datamintelligence.com/research-report/live-attenuated-vaccines-market

Our research report gives wide perceptions of the latest trends and development prospects of the market analysis, detailed segmentation analysis, volume, size, share, growth drives, and opportunities in the market. In-depth regional and country-level illustration of the competitive landscape depends on several phases and status of clinical trials over the prominent economies of the globe, and also report contains a number of major companies profiled in the relevant market.

Market Drivers:
The expansion in irresistible sicknesses has influenced the existences of various individuals. To forestall contaminations various new immunizations have been presented. The expansion in advancements of new immunizations has raised the development of the market.

For example, As per NIH, it is assessed that around 10.6 million individuals became sick with TB overall in 2021 an increment of 4.5% from 10.1 million of every 2020. Also, TB cases have expanded from 7,874 cases in 2021 to 8,300 out of 2022 in US. Moreover, as per CDC, it is assessed that flu has impacted 9 million individuals overall during the year 2021-2022. An expansion in the weight of irresistible illnesses expands the interest for immunizations. Hence, an expansion in the quantity of irresistible illnesses is supposed to drive the market development. An expansion in immunization dispatches and an expansion in infants are additionally the driving elements of the market development. A portion of the limits of live weakened viral immunizations incorporate inversion to destructiveness, tissue harm, and others. Tissue harm because of live antibodies can prompt obsessive problems or optional bacterial diseases. Unfriendly responses, for example, fever or rash following live, weakened immunizations are like a gentle type of the normal illness.

Download Sample Report at: https://www.datamintelligence.com/download-sample/live-attenuated-vaccines-market

Market Segmentation:

By Type
By Development
By End-User
By Region

Major Companies Covered:
Merck & Co., Inc., GlaxoSmithKline plc, Pfizer Inc., Sanofi, Astellas Pharma, CSL Limited, Serum Institute of India Pvt. Ltd., BioDiem, AstraZeneca, Emergent BioSolutions Inc., and Vivaldi Biosciences Inc., among others.

Trending Topics:
Vaccine Refrigerators Market: https://www.datamintelligence.com/research-report/vaccine-refrigerators-market
Hepatitis A Vaccine Market: https://www.datamintelligence.com/research-report/hepatitis-a-vaccine-market
Vaccine Adjuvants Market: https://www.datamintelligence.com/research-report/vaccine-adjuvants-market

DataM Intelligence 4market Research LLP Ground floor, DSL Abacus IT Park, Industrial Development Area, Uppal, Hyderabad, Telangana 500039.

DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Live Attenuated Vaccines Market Size, Share, Volume and Forecast Report 2023-2030 here

News-ID: 3270434 • Views:

More Releases from DataM Intelligence 4Market Research

Blood Clotting Factors Market Set for Breakthrough Growth Driven by Advanced Biologics and Novel Therapies 2025 | Top key players - Shire Plc, Baxter International Inc., Grifols International SA.
Blood Clotting Factors Market Set for Breakthrough Growth Driven by Advanced Bio …
Market Overview: The Blood Clotting Factors Market is predicted to reach at a CAGR of 6.9% during the forecast period (2024-2031). The Blood Clotting Factors Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Blood Clotting Factors market report is an essential
Autoimmune Treatment Market Accelerates Amid Breakthrough Therapies and Rising Patient Demand 2025 | Top key players - Abbott Laboratories, Amgen, Johnson & Johnson.
Autoimmune Treatment Market Accelerates Amid Breakthrough Therapies and Rising P …
Market Overview: The Global Autoimmune Treatment Market is predicted to reach at a Significant CAGR during the forecast period (2024-2031). The Autoimmune Treatment Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Autoimmune Treatment market report is an essential resource for market
Immunology Drugs Market Poised for Breakthrough Growth Amid Rising Autoimmune and Inflammatory Disorder Cases 2025 | Top key players - Eli-Lilly, Novartis, AbbVie.
Immunology Drugs Market Poised for Breakthrough Growth Amid Rising Autoimmune an …
Market Size and Growth: The Global Immunology Drugs Market Size reached US$ 91.97 billion in 2023 and is expected to reach US$ 148.62 billion by 2031, growing at a CAGR of 6.35% during the forecast period 2024-2031. The Immunology Drugs Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants
Inactivated Vaccines Market Poised for Robust Growth Amid Rising Immunization Demand 2025 | Major key players - GSK plc., Sanofi., Biological E Limited., Bharat Biotech.
Inactivated Vaccines Market Poised for Robust Growth Amid Rising Immunization De …
Market Size and Growth: The Global Inactivated Vaccines Market Size reached US$22.60 billion in 2024 and is expected to reach US$34.26 billion by 2033, growing at a CAGR of 4.8% during the forecast period 2024-2032. The Inactivated Vaccines Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize

All 5 Releases


More Releases for Vaccine

Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Download Sample PDF at  https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis:  AstraZeneca  Bharat Biotech  Dynavax Technologies Corporation  GlaxoSmithKline  Johnson & Johnson  Merck and Co  Novartis  Pfizer  Sanofi Pasteur  Serum Institute of India The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion